Skip to main content

Animations

MJFF Publications

5131 - 5140 of 6422 Results
Title
Year
  • Year
  • 2023
  • 2018
  • 2018
  • 2021
  • 2010
  • 2021
  • 2017
  • 2022
  • 2018
  • 2017
  • Summary Details
    OPEN
    Title: New protocol for kinetic assay seeding ability recovery “KASAR” from formalin-fixed paraffin-embedded tissues
    Journal Name: Frontiers in Molecular Biosciences
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fmolb.2023.1087982
    Citation Count: 9
  • Summary Details
    OPEN
    Title: 5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.09.018
    Citation Count: 34
  • Summary Details
    OPEN
    Title: Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches
    Journal Name: Bioconjugate Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.8b00548
    Citation Count: 53
  • Summary Details
    OPEN
    Title: 4R-cembranoid protects neuronal cells from oxygen–glucose deprivation by modulating microglial cell activation
    Journal Name: Brain Research Bulletin
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brainresbull.2021.12.007
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Dystrophin-associated protein scaffolding in brain requires α-dystrobrevin
    Journal Name: NeuroReport
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wnr.0b013e32833b0a3b
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Advances in protein-protein interaction network analysis for Parkinson's disease
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395
    Citation Count: 68
  • Summary Details
    OPEN
    Title: Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease
    Journal Name: Molecular Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13024-017-0154-3
    Citation Count: 266
  • Summary Details
    OPEN
    Title: Six Action Steps to Address Global Disparities in Parkinson Disease
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1783
    Citation Count: 115
  • Summary Details
    OPEN
    Title: The atypical RhoGTPase RhoE/Rnd3 is a key molecule to acquire a neuroprotective phenotype in microglia
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-018-1386-z
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson’s disease
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0186508
    Citation Count: 39
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.